Background Clinical benefit of percutaneous coronary intervention (PCI) in chronic coronary syndromes (CCS) remains ...
Over the last 33 years, acting on modifiable risk factors has helped to prevent deaths caused by ischemic heart disease, new ...
VahatiCor CEO Harry Rowland explains how the nitinol A-Flux reducer implant is designed to treat coronary microvascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results